US Patent 10894774 Enhanced erythropoiesis and iron metabolism
Patent 10894774 was granted and assigned to Fibrogen, Inc. on January, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10894774 Enhanced erythropoiesis and iron metabolism
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.